0
Sign In  | Subscribe
17 October 2006, Vol 145, No. 8>
Summaries for Patients | 17 October 2006

Can Antibiotics Improve the Symptoms of the Irritable Bowel Syndrome? FREE

[+] Article and Author Information

The summary below is from the full report titled “The Effect of a Nonabsorbed Oral Antibiotic (Rifaximin) on the Symptoms of the Irritable Bowel Syndrome. A Randomized Trial.” It is in the 17 October 2006 issue of Annals of Internal Medicine (volume 145, pages 557-563). The authors are M. Pimentel, S. Park, J. Mirocha, S.V. Kane, and Y. Kong.


Ann Intern Med. 2006;145(8):I-24. doi:10.7326/0003-4819-145-8-200610170-00001
Text Size: A A A

What is the problem and what is known about it so far?

The irritable bowel syndrome (IBS) causes symptoms of cramping, bloating, gas, diarrhea, and constipation for no apparent reason. The cause of IBS is uncertain, but some evidence suggests that IBS is caused by an abnormal growth of bacteria. If bacteria contribute to IBS, then treatment with antibiotics might be helpful.

Why did the researchers do this particular study?

To determine whether rifaximin, an antibiotic that works only in the gut, can improve symptoms in people with IBS.

Who was studied?

87 people with IBS at 2 medical centers.

How was the study done?

After recording symptoms for a week in a symptom diary, participants were assigned at random to receive rifaximin or placebo for 10 days. They recorded their symptoms weekly for 10 weeks after they stopped taking the drug or placebo. The researchers then compared the severity of symptoms in the 2 groups.

What did the researchers find?

Bloating and overall symptoms improved in participants who took the antibiotic. However, the researchers could not detect a difference in symptoms of diarrhea or constipation. Rifaximin did not cause any clinically significant side effects.

What were the limitations of the study?

A relatively small number of patients and a short duration limited the study's findings. The findings might differ if more participants were studied and if patients were followed for a longer period of time.

What are the implications of the study?

Rifaximin taken for 10 days seems to provide some relief of symptoms to people with IBS.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general jounals
BMJ 2010;341:c5893-c1494.

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Advertisement

Related Content

Customize your page view by dragging & repositioning the boxes below.

In the Clinic
Community-Acquired Pneumonia
Ann Intern Med. 2009;151(7):ITC4-1.
Irritable Bowel Syndrome
Ann Intern Med. 2007;147(1):ITC7-1.
Topic Collections
PubMed Articles
Mechanisms and effectiveness of prebiotics in modifying the gastrointestinal microbiota for the management of digestive disorders.
The Proceedings of the Nutrition Society Issue date: 2013 May 17
Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome.
Expert opinion on pharmacotherapy Issue date: 2013 Jun

Annals of Internal Medicine

Other Resources

Copyright © 2013 The American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)